Minetta Liu

Minetta Liu is a Professor of Oncology and Director of the Translational Liquid Biopsy Program at Mayo Clinic. She is one of the leading clinical translational researchers for ctDNA-based liquid biopsy in breast cancer and other solid tumors. Liu leads major clinical trials investigating ctDNA as a biomarker for residual disease detection, treatment response monitoring, and ctDNA-guided treatment escalation/de-escalation in early-stage breast cancer. She has been principal investigator on multiple NCI-funded ctDNA breast cancer studies and has published defining clinical validation studies. She is particularly focused on translating liquid biopsy from research settings to standard clinical oncology practice, with emphasis on breast cancer and multi-cancer early detection approaches.

Minetta Liu 是梅奥诊所肿瘤学教授和转化液体活检项目主任。她是乳腺癌和其他实体肿瘤中基于ctDNA的液体活检领域最领先的临床转化研究者之一。 Liu 领导着调查ctDNA作为早期乳腺癌残留病灶检测、治疗反应监测以及ctDNA引导治疗升级/降级的生物标志物的主要临床试验。